Sleep Apnea
Conditions
Interventions
Data collection will be performed before the first procedure and at the end of the 16th session of low level LASER, with Target sample size: 36 participants.
Group 1: 18 participants will receive Trea
Device
E02.774
Sponsors
Universidade Nove de Julho
Universidade Nove de Julho
Eligibility
Age
30 Years to 60 Years
Inclusion criteria
Inclusion criteria: Score in two or more positive categories in the Berlin Questionnaire; when performing the polysomnography examination, the apnea and hypopnea index should be greater than or equal to 15 events per hour of sleep (AHI> 15 / h).
Exclusion criteria
Exclusion criteria: Pediatric, eudaphic and elderly patients; patients with diagnosed central apnea; alcoholic patients, smokers, oncologists, pneumopathies, patients with heart disease and with hypothyroidism; pregnant women; or patients with a history of photosensitivity (allergic). Participants unable to understand and sign the TCLE.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| As a primary endpoint, the effect of low level LASER photobiomodulation therapy is expected to reduce apnea / hypopnea index. Measurements will be taken before and after the 16 sessions. | — |
Secondary
| Measure | Time frame |
|---|---|
| As a secondary endpoint, the chronic effect of low level LASER photobiomodulation therapy is expected to improve collapsibility, autonomic control, hemodynamic control, and blood inflammatory markers in individuals with Obstructive Sleep Apnea. Measurements will be taken before and after the 16 sessions. | — |
Countries
Brazil
Contacts
Public ContactFernanda ;Fernanda Ferreira de Camargo;Ferreira de Camargo
Universidade Nove de Julho;Universidade Nove de Julho
Outcome results
None listed